Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Subscribe to see Circle Pharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Circle Pharma, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $92.4M in June 2024. Xcout tracks 4 named people at Circle Pharma, Inc., including Anne Borgman (Chief Medical Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $92.4M | — | |
| — | $66M | 3 named | |
| SEC Form D filing | $15M | — | |
| — | $45M | 3 named | |
| SEC Form D filing | $3.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Circle Pharma, Inc.'s closest competitors — see the full list of competitors and alternatives →
Curve Therapeutics is a private biotechnology company headquartered in Southampton, United Kingdom, pioneering a revolutionary proprietary microcycle drug discovery platform to address challenging intracellular targets.
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
Lycia Therapeutics, Inc. is a leader in extracellular protein degradation, headquartered in South San Francisco, California.
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The firm is driven by its mission to develop oral small molecule therapies to treat inflammatory and immunologic diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.